What is it about?
Evidence-based review of ocrelizumab
Featured Image
Why is it important?
Review intended for formulary evaluation
Perspectives
Review intended for formulary evaluation
Danial Baker
Washington State University
Read the Original
This page is a summary of: Formulary Drug Review: Ocrelizumab, Hospital Pharmacy, September 2017, SAGE Publications,
DOI: 10.1177/0018578717731733.
You can read the full text:
Contributors
The following have contributed to this page
